Биология ва тиббиёт муаммолари 2025, №4.1 (164)

Maqola mavzusi

MORPHOFUNCTIONAL FEATURES IN PATIENTS WITH DUODENAL ULCER UNDER THE INFLUENCE OF PHYSICAL FACTORS (132-135)

Mualliflar

Khamrabaeva Feruza Ibragimovna

Muassasa

Center for the Development of Professional Qualifications of Medical Workers, Republic of Uzbekistan, Tashkent

Annotatsiya

This study investigates the morphofunctional changes in the duodenal mucosa in patients with duodenal ulcers (DU), particularly in relation to Helicobacter pylori infection and the use of physical therapy methods. A total of 57 patients were divided into groups receiving different combinations of physical therapies—centimeter-wave (CMW) therapy and transcranial electrical stimulation (TES)—in addition to standard eradication treatment. Histological examination focused on epithelial integrity, villous architecture, cellular infiltration, and stromal changes. Results showed that physical therapies contributed to significant improvements in mucosal structure, with reduced inflammatory infiltration and improved epithelial regeneration. The addition of CMW and TES therapy enhanced the therapeutic effect compared to standard treatment alone, likely due to better modulation of immune-inflammatory responses and more effective eradication of H. pylori.

Kalit so'zlar

Duodenal ulcer, Helicobacter pylori, Physical therapy, Morphological changes.

Adabiyotlar

1. Possibilities of probiotic therapy for Helicobacter-associated gastritis / A.I. Khavkin et al // Pediatrics (Journal named after G.N. Speransky). - M., 2007. - No. 4. - p. 115-118 2. Ivashkin V. T., Lapina T. L. Treatment of peptic ulcer: new century - new achievements - new issues // Diseases of the digestive system (for specialists and general practitioners). - M., 2012. - N 1. - p. 20-24 3. Isakov V. A., Maev I. V., Ganskaya Zh. Yu., E I. Podgorbunskikh // Experimental and Clinical Gastroenterology. - M., 2013. - N 3. - pp. 8-11 4. Standards "Diagnostics and therapy of acid-dependent diseases, including those associated with Helicobacter pylori". Third Moscow Agreement, 4 Feb. 2005 / Ed. L. B. Lazebnika, Yu. V. Vasilyeva // Experimental and Clinical Gastroenterology.- M., 2015.- No. 3. pp. 3–6 5. Zimmerman Ya.S. Peptic ulcer and the problem of Helicobacter pylori infection: new facts, reflections, assumptions // Clinical Medicine. - M., 2001. - No. 4. - p. 67-70 6. Shakurova N. R. Clinical aspects of Helicobacter pulori-associated peptic ulcer and morphofunctional changes in the mucous membrane of the stomach and duodenum // Bulletin of Siberian Medicine. - Tomsk, 2008. - N 1. - p. 88-94 7. The effectiveness of therapy for peptic ulcer / M.N. Bendinger, W.G. Berdiev, U.K. Kamilova et al. // Actual problems of diagnostics, treatment and medical rehabilitation of diseases of internal organs: Proceedings. Republican scientific - pract. conf. (September 20-21, 2007, Tashkent). - T., 2007. - p. 112 8. Helicobacter pylori. Basic Mechanisms to Clinical Cure 1998 / Eds. R.H. Hunt, G.J. Tytgat.-Dordrecht; Boston; London, 1998.-153 p. 9. Helicobacter pylori: A review of the World Literature // Axan Pharma.-2009.-N 18.-P.69-88 10. Helicobacter pylori infection and gastric metaplasia in the duodenim in China / H. T. Yang, M.F. Dixon, Z.S. Zuo et al., Clin. Gastoenterol.-2005.-N20.-P.110-112 11. High rate of post-therapeutic resisitance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: Impact of two second-kine therapies in a randomized study / U. Peitz, M. Sulliga, K. Wolle et al // Aliment. Pharmacol. Ther.-2002.-N16.-P.315-322